Hap Trading, LLC Bio N Tech Se Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$123.25 - $186.24 $135,575 - $204,864	-1,100 Reduced 8.53%	11,800 $132,000
Q1 2022 May 12, 2022	SELL	$126.25 - $231.85 $2.08 Million - $3.83 Million	-16,500 Reduced 56.12%	12,900 $212,000
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $714,912 - $1.2 Million	-3,300 Reduced 10.09%	29,400 $2.06 Million
Q3 2021 Nov 10, 2021	BUY	$205.93 - $447.23 $1.26 Million - $2.73 Million	6,100 Added 22.93%	32,700 $2.76 Million
Q2 2021 Aug 11, 2021	BUY	$113.32 - $241.49 $815,904 - $1.74 Million	7,200 Added 37.11%	26,600 $1.96 Million
Q1 2021 May 14, 2021	SELL	$85.73 - $119.5 $865,873 - $1.21 Million	-10,100 Reduced 34.24%	19,400 $227,000
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $959,771 - $1.71 Million	-13,200 Reduced 30.91%	29,500 $197,000
Q3 2020 Nov 13, 2020	BUY	$57.81 - $104.17 $2.47 Million - $4.45 Million	42,700 New	42,700 $752,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.